- Home
- PAVS vs TLSA Comparison
PAVS vs TLSA Comparison
Compare PAVS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- TLSA
- Stock Information
- Founded
- PAVS 2004
- TLSA 2013
- Country
- PAVS United States
- TLSA United Kingdom
- Employees
- PAVS N/A
- TLSA N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- TLSA Health Care
- Exchange
- PAVS Nasdaq
- TLSA Nasdaq
- Market Cap
- PAVS 49.1M
- TLSA 187.0M
- IPO Year
- PAVS 2019
- TLSA 2000
- Fundamental
- Price
- PAVS $0.81
- TLSA $1.78
- Analyst Decision
- PAVS
- TLSA
- Analyst Count
- PAVS 0
- TLSA 0
- Target Price
- PAVS N/A
- TLSA N/A
- AVG Volume (30 Days)
- PAVS 453.4K
- TLSA 330.7K
- Earning Date
- PAVS 08-04-2025
- TLSA 05-06-2025
- Dividend Yield
- PAVS N/A
- TLSA N/A
- EPS Growth
- PAVS N/A
- TLSA N/A
- EPS
- PAVS N/A
- TLSA N/A
- Revenue
- PAVS $71,542.00
- TLSA N/A
- Revenue This Year
- PAVS N/A
- TLSA N/A
- Revenue Next Year
- PAVS N/A
- TLSA N/A
- P/E Ratio
- PAVS N/A
- TLSA N/A
- Revenue Growth
- PAVS N/A
- TLSA N/A
- 52 Week Low
- PAVS $0.32
- TLSA $0.63
- 52 Week High
- PAVS $1.50
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- PAVS 51.67
- TLSA 49.08
- Support Level
- PAVS $0.76
- TLSA $1.63
- Resistance Level
- PAVS $0.90
- TLSA $1.88
- Average True Range (ATR)
- PAVS 0.13
- TLSA 0.16
- MACD
- PAVS 0.01
- TLSA -0.00
- Stochastic Oscillator
- PAVS 34.89
- TLSA 69.23
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.